Vice President Vaccine Development
Vice President Vaccine Development
The success of a company depends on the passionate people we partner with.
Together, let's share our talents.
As a global leader in animal health, Ceva Animal Health believes our success is linked to our passionate people researching, developing , producing and supplying innovative health solutions for all animals, which contributes to the future of our diverse planet.
We are committed to ensuring the highest possible level of care and well\-being for farm animals (poultry, pigs, ruminants), companion animals (dogs and cats) and wildlife.
Indeed, Our “Together, Beyond Animal Health” vision emphasizes that the health and wellbeing of people, animals and our planet are totally interlinked. More than ever, Ceva is committed to a "One Health" approach.
As part of our “Diversity, Equity and Inclusion” policy, Ceva Animal Heath is committed to the employment of people with disabilities and will make reasonable accommodations throughout the interview process to ensure an inclusive and accessible experience for all applicants. To request an accommodation, please contact a member of the Ceva Talent Acquisition team.
Your missions :
Job Location: Europe (preferably France)
Ceva Santé Animale is strengthening its global R\&D organization and accelerating its ambition in vaccines and biologicals.
As part of this transformation, we are creating a Vice President – Vaccine Development role to lead and elevate our global development capabilities.
The role provides senior leadership across all vaccine development domains, ensuring scientific, regulatory, manufacturing and portfolio coherence from the development stagegate through registration readiness, while aligning with Discovery innovation, technology platforms and development execution under a single, integrated vision.
As a direct manager of multiple Senior Vaccine Leaders, the VP Vaccine Development drives clarity of priorities, consistency of execution and portfolio‑level value creation, while acting as a key decision‑making authority within R\&D governance.
Key Responsibilities
Reporting to the EVP R\&D, the VP Vaccine Development will:
- Define and implement a clear, differentiated global vaccine development strategy aligned with portfolio and business priorities
- Lead portfolio prioritization, value optimization, and trade\-offs across multiple development programs
- Establish robust governance, decision\-making frameworks, and execution standards across vaccine development
- Drive the transformation of the organization, including structure, operating model, and capabilities
- Lead and develop a global team of senior leaders across multiple sites and domains
- Ensure strong cross\-functional integration with Discovery, Regulatory, Manufacturing and Commercial teams
- Accelerate delivery of key strategic programs in a fast and highly competitive environment
- Foster a high\-performance, accountable, and collaborative culture across the organization
- Advanced degree (PhD, DVM, MD or equivalent) in life sciences
- 15\+ years of experience in vaccines or biologics development, within pharma, biotech, or animal health
- Proven track record of end\-to\-end vaccine development, including successful product licensing
- Strong experience in portfolio\-level leadership, prioritization, and strategic decision\-making
- Demonstrated ability to lead large, global, and matrix organizations
- Solid understanding of regulatory pathways, CMC, and industrial constraints
- Expertise in livestock (particularly swine and ruminants) is highly desirable
- Recognized as a transformational leader, able to drive change in complex environments
- Combines strategic vision with pragmatic execution and strong decision\-making
- Lead a global transformation of vaccine development in a fast\-growing, innovation\-driven company
- Shape the future of a strategic and high\-value portfolio
- Operate at executive level with strong visibility and influence
- Opportunity to build and scale best\-in\-class R\&D capabilities
Cette annonce provient de indeed. Voir l'annonce originale ↗